Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

February 8, 2017

Primary Completion Date

September 30, 2021

Study Completion Date

October 30, 2021

Conditions
Incomplete HCT (Hematopoietic Cell Transplantation)
Interventions
BIOLOGICAL

PLX-R18

Intramuscular (IM) administration of PLX-R18

Trial Locations (10)

21201

University of Maryland Medical Center,22 South Greene Street, Baltimore

44106

University Hospitals Case Medical Center, Cleveland

55905

Mayo Clinic Cancer Center (MCCC) - Rochester,200 1st Street SW, Rochester

75246

Baylor University Medical Center, Dallas

60637-1447

The University of Chicago Medical Center, Chicago

66205-2005

University of Kansas Cancer Center - The Richard and Annette Bloch Cancer Care Pavilion,2330 Shawnee Mission Parkway, Westwood

07601

Hackensack University Medical Center, Hackensack

Unknown

Rambam Medical Center, Haifa

Hadassah Ein Karem Medical Center, Jerusalem

Sheba Medical Center, Ramat Gan

All Listed Sponsors
lead

Pluristem Ltd.

INDUSTRY

NCT03002519 - Safety Evaluation of Intramuscular Injections of PLX-R18 in Subjects With Incomplete Hematopoietic Recovery Following Hematopoietic Cell Transplantation | Biotech Hunter | Biotech Hunter